nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosentan—ABCB11—Dexamethasone—ankylosing spondylitis	0.302	0.44	CbGbCtD
Bosentan—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0821	0.12	CbGbCtD
Bosentan—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0622	0.0906	CbGbCtD
Bosentan—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0534	0.0777	CbGbCtD
Bosentan—CYP3A4—Betamethasone—ankylosing spondylitis	0.0534	0.0777	CbGbCtD
Bosentan—CYP3A4—Prednisolone—ankylosing spondylitis	0.0527	0.0767	CbGbCtD
Bosentan—CYP3A4—Prednisone—ankylosing spondylitis	0.0497	0.0724	CbGbCtD
Bosentan—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0311	0.0452	CbGbCtD
Bosentan—Infestation—Methotrexate—ankylosing spondylitis	0.000505	0.00161	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000504	0.00161	CcSEcCtD
Bosentan—Flushing—Prednisone—ankylosing spondylitis	0.000503	0.00161	CcSEcCtD
Bosentan—Discomfort—Triamcinolone—ankylosing spondylitis	0.000502	0.0016	CcSEcCtD
Bosentan—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000501	0.0016	CcSEcCtD
Bosentan—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.0005	0.0016	CcSEcCtD
Bosentan—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000497	0.00159	CcSEcCtD
Bosentan—Renal failure—Methotrexate—ankylosing spondylitis	0.000496	0.00158	CcSEcCtD
Bosentan—Angioedema—Betamethasone—ankylosing spondylitis	0.000495	0.00158	CcSEcCtD
Bosentan—Angioedema—Dexamethasone—ankylosing spondylitis	0.000495	0.00158	CcSEcCtD
Bosentan—Stomatitis—Methotrexate—ankylosing spondylitis	0.000492	0.00157	CcSEcCtD
Bosentan—Angiopathy—Prednisone—ankylosing spondylitis	0.000492	0.00157	CcSEcCtD
Bosentan—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000491	0.00157	CcSEcCtD
Bosentan—Immune system disorder—Prednisone—ankylosing spondylitis	0.00049	0.00156	CcSEcCtD
Bosentan—Oedema—Triamcinolone—ankylosing spondylitis	0.000487	0.00156	CcSEcCtD
Bosentan—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000487	0.00156	CcSEcCtD
Bosentan—Vertigo—Dexamethasone—ankylosing spondylitis	0.000487	0.00156	CcSEcCtD
Bosentan—Vertigo—Betamethasone—ankylosing spondylitis	0.000487	0.00156	CcSEcCtD
Bosentan—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000486	0.00155	CcSEcCtD
Bosentan—Syncope—Dexamethasone—ankylosing spondylitis	0.000486	0.00155	CcSEcCtD
Bosentan—Syncope—Betamethasone—ankylosing spondylitis	0.000486	0.00155	CcSEcCtD
Bosentan—Infection—Triamcinolone—ankylosing spondylitis	0.000484	0.00155	CcSEcCtD
Bosentan—Infection—Methylprednisolone—ankylosing spondylitis	0.000483	0.00154	CcSEcCtD
Bosentan—Haematuria—Methotrexate—ankylosing spondylitis	0.000481	0.00154	CcSEcCtD
Bosentan—Shock—Triamcinolone—ankylosing spondylitis	0.00048	0.00153	CcSEcCtD
Bosentan—Insomnia—Prednisolone—ankylosing spondylitis	0.000479	0.00153	CcSEcCtD
Bosentan—Shock—Methylprednisolone—ankylosing spondylitis	0.000479	0.00153	CcSEcCtD
Bosentan—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000477	0.00152	CcSEcCtD
Bosentan—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000477	0.00152	CcSEcCtD
Bosentan—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000476	0.00152	CcSEcCtD
Bosentan—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000476	0.00152	CcSEcCtD
Bosentan—Epistaxis—Methotrexate—ankylosing spondylitis	0.000476	0.00152	CcSEcCtD
Bosentan—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000476	0.00152	CcSEcCtD
Bosentan—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000476	0.00152	CcSEcCtD
Bosentan—Mental disorder—Prednisone—ankylosing spondylitis	0.000475	0.00152	CcSEcCtD
Bosentan—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000475	0.00152	CcSEcCtD
Bosentan—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000472	0.00151	CcSEcCtD
Bosentan—Malnutrition—Prednisone—ankylosing spondylitis	0.000472	0.00151	CcSEcCtD
Bosentan—Erythema—Prednisone—ankylosing spondylitis	0.000472	0.00151	CcSEcCtD
Bosentan—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000471	0.00151	CcSEcCtD
Bosentan—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00047	0.0015	CcSEcCtD
Bosentan—Anxiety—Betamethasone—ankylosing spondylitis	0.00046	0.00147	CcSEcCtD
Bosentan—Anxiety—Dexamethasone—ankylosing spondylitis	0.00046	0.00147	CcSEcCtD
Bosentan—Discomfort—Dexamethasone—ankylosing spondylitis	0.000456	0.00146	CcSEcCtD
Bosentan—Discomfort—Betamethasone—ankylosing spondylitis	0.000456	0.00146	CcSEcCtD
Bosentan—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000455	0.00145	CcSEcCtD
Bosentan—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000455	0.00145	CcSEcCtD
Bosentan—Pain—Prednisolone—ankylosing spondylitis	0.000453	0.00145	CcSEcCtD
Bosentan—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000453	0.00145	CcSEcCtD
Bosentan—Hepatitis—Methotrexate—ankylosing spondylitis	0.000453	0.00145	CcSEcCtD
Bosentan—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000447	0.00143	CcSEcCtD
Bosentan—Vision blurred—Prednisone—ankylosing spondylitis	0.000445	0.00142	CcSEcCtD
Bosentan—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000444	0.00142	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000444	0.00142	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000443	0.00142	CcSEcCtD
Bosentan—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000442	0.00141	CcSEcCtD
Bosentan—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000442	0.00141	CcSEcCtD
Bosentan—Oedema—Betamethasone—ankylosing spondylitis	0.000442	0.00141	CcSEcCtD
Bosentan—Oedema—Dexamethasone—ankylosing spondylitis	0.000442	0.00141	CcSEcCtD
Bosentan—Insomnia—Triamcinolone—ankylosing spondylitis	0.000441	0.00141	CcSEcCtD
Bosentan—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00044	0.00141	CcSEcCtD
Bosentan—Infection—Betamethasone—ankylosing spondylitis	0.000439	0.0014	CcSEcCtD
Bosentan—Infection—Dexamethasone—ankylosing spondylitis	0.000439	0.0014	CcSEcCtD
Bosentan—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000438	0.0014	CcSEcCtD
Bosentan—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000437	0.0014	CcSEcCtD
Bosentan—Anaemia—Prednisone—ankylosing spondylitis	0.000436	0.00139	CcSEcCtD
Bosentan—Shock—Dexamethasone—ankylosing spondylitis	0.000435	0.00139	CcSEcCtD
Bosentan—Shock—Betamethasone—ankylosing spondylitis	0.000435	0.00139	CcSEcCtD
Bosentan—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000435	0.00139	CcSEcCtD
Bosentan—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000434	0.00139	CcSEcCtD
Bosentan—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000434	0.00139	CcSEcCtD
Bosentan—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000433	0.00138	CcSEcCtD
Bosentan—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000433	0.00138	CcSEcCtD
Bosentan—Tachycardia—Betamethasone—ankylosing spondylitis	0.000432	0.00138	CcSEcCtD
Bosentan—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000432	0.00138	CcSEcCtD
Bosentan—Angioedema—Prednisone—ankylosing spondylitis	0.000431	0.00138	CcSEcCtD
Bosentan—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000429	0.00137	CcSEcCtD
Bosentan—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000428	0.00137	CcSEcCtD
Bosentan—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000428	0.00137	CcSEcCtD
Bosentan—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000428	0.00137	CcSEcCtD
Bosentan—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000428	0.00137	CcSEcCtD
Bosentan—Vertigo—Prednisone—ankylosing spondylitis	0.000424	0.00135	CcSEcCtD
Bosentan—Eye disorder—Methotrexate—ankylosing spondylitis	0.000423	0.00135	CcSEcCtD
Bosentan—Syncope—Prednisone—ankylosing spondylitis	0.000423	0.00135	CcSEcCtD
Bosentan—Tinnitus—Methotrexate—ankylosing spondylitis	0.000422	0.00135	CcSEcCtD
Bosentan—Anorexia—Betamethasone—ankylosing spondylitis	0.000422	0.00135	CcSEcCtD
Bosentan—Anorexia—Dexamethasone—ankylosing spondylitis	0.000422	0.00135	CcSEcCtD
Bosentan—Urticaria—Prednisolone—ankylosing spondylitis	0.000421	0.00135	CcSEcCtD
Bosentan—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000421	0.00134	CcSEcCtD
Bosentan—Fatigue—Triamcinolone—ankylosing spondylitis	0.00042	0.00134	CcSEcCtD
Bosentan—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000419	0.00134	CcSEcCtD
Bosentan—Pain—Triamcinolone—ankylosing spondylitis	0.000417	0.00133	CcSEcCtD
Bosentan—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000415	0.00133	CcSEcCtD
Bosentan—Hypotension—Betamethasone—ankylosing spondylitis	0.000413	0.00132	CcSEcCtD
Bosentan—Hypotension—Dexamethasone—ankylosing spondylitis	0.000413	0.00132	CcSEcCtD
Bosentan—Angiopathy—Methotrexate—ankylosing spondylitis	0.000411	0.00131	CcSEcCtD
Bosentan—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000409	0.00131	CcSEcCtD
Bosentan—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000408	0.0013	CcSEcCtD
Bosentan—Chills—Methotrexate—ankylosing spondylitis	0.000407	0.0013	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000403	0.00129	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000403	0.00129	CcSEcCtD
Bosentan—Arthralgia—Prednisone—ankylosing spondylitis	0.000402	0.00128	CcSEcCtD
Bosentan—Anxiety—Prednisone—ankylosing spondylitis	0.0004	0.00128	CcSEcCtD
Bosentan—Insomnia—Betamethasone—ankylosing spondylitis	0.0004	0.00128	CcSEcCtD
Bosentan—Insomnia—Dexamethasone—ankylosing spondylitis	0.0004	0.00128	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000399	0.00127	CcSEcCtD
Bosentan—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000398	0.00127	CcSEcCtD
Bosentan—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000397	0.00127	CcSEcCtD
Bosentan—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000397	0.00127	CcSEcCtD
Bosentan—Discomfort—Prednisone—ankylosing spondylitis	0.000397	0.00127	CcSEcCtD
Bosentan—Mental disorder—Methotrexate—ankylosing spondylitis	0.000397	0.00127	CcSEcCtD
Bosentan—Erythema—Methotrexate—ankylosing spondylitis	0.000394	0.00126	CcSEcCtD
Bosentan—Malnutrition—Methotrexate—ankylosing spondylitis	0.000394	0.00126	CcSEcCtD
Bosentan—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000391	0.00125	CcSEcCtD
Bosentan—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000389	0.00124	CcSEcCtD
Bosentan—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000389	0.00124	CcSEcCtD
Bosentan—Urticaria—Triamcinolone—ankylosing spondylitis	0.000387	0.00124	CcSEcCtD
Bosentan—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000386	0.00123	CcSEcCtD
Bosentan—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000385	0.00123	CcSEcCtD
Bosentan—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000385	0.00123	CcSEcCtD
Bosentan—Oedema—Prednisone—ankylosing spondylitis	0.000385	0.00123	CcSEcCtD
Bosentan—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000385	0.00123	CcSEcCtD
Bosentan—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000385	0.00123	CcSEcCtD
Bosentan—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000385	0.00123	CcSEcCtD
Bosentan—Infection—Prednisone—ankylosing spondylitis	0.000383	0.00122	CcSEcCtD
Bosentan—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000382	0.00122	CcSEcCtD
Bosentan—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000382	0.00122	CcSEcCtD
Bosentan—Back pain—Methotrexate—ankylosing spondylitis	0.000382	0.00122	CcSEcCtD
Bosentan—Fatigue—Dexamethasone—ankylosing spondylitis	0.000381	0.00122	CcSEcCtD
Bosentan—Fatigue—Betamethasone—ankylosing spondylitis	0.000381	0.00122	CcSEcCtD
Bosentan—Shock—Prednisone—ankylosing spondylitis	0.000379	0.00121	CcSEcCtD
Bosentan—Pain—Dexamethasone—ankylosing spondylitis	0.000378	0.00121	CcSEcCtD
Bosentan—Pain—Betamethasone—ankylosing spondylitis	0.000378	0.00121	CcSEcCtD
Bosentan—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000378	0.00121	CcSEcCtD
Bosentan—Tachycardia—Prednisone—ankylosing spondylitis	0.000376	0.0012	CcSEcCtD
Bosentan—Skin disorder—Prednisone—ankylosing spondylitis	0.000374	0.0012	CcSEcCtD
Bosentan—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000372	0.00119	CcSEcCtD
Bosentan—Vision blurred—Methotrexate—ankylosing spondylitis	0.000372	0.00119	CcSEcCtD
Bosentan—Anorexia—Prednisone—ankylosing spondylitis	0.000367	0.00117	CcSEcCtD
Bosentan—Anaemia—Methotrexate—ankylosing spondylitis	0.000365	0.00116	CcSEcCtD
Bosentan—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000362	0.00116	CcSEcCtD
Bosentan—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000362	0.00116	CcSEcCtD
Bosentan—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000359	0.00115	CcSEcCtD
Bosentan—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000358	0.00114	CcSEcCtD
Bosentan—Vertigo—Methotrexate—ankylosing spondylitis	0.000354	0.00113	CcSEcCtD
Bosentan—Leukopenia—Methotrexate—ankylosing spondylitis	0.000353	0.00113	CcSEcCtD
Bosentan—Urticaria—Betamethasone—ankylosing spondylitis	0.000351	0.00112	CcSEcCtD
Bosentan—Urticaria—Dexamethasone—ankylosing spondylitis	0.000351	0.00112	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000351	0.00112	CcSEcCtD
Bosentan—Dizziness—Prednisolone—ankylosing spondylitis	0.000351	0.00112	CcSEcCtD
Bosentan—Asthenia—Triamcinolone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Bosentan—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Bosentan—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Bosentan—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Bosentan—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00035	0.00112	CcSEcCtD
Bosentan—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000349	0.00111	CcSEcCtD
Bosentan—Insomnia—Prednisone—ankylosing spondylitis	0.000348	0.00111	CcSEcCtD
Bosentan—Paraesthesia—Prednisone—ankylosing spondylitis	0.000346	0.0011	CcSEcCtD
Bosentan—Pruritus—Triamcinolone—ankylosing spondylitis	0.000345	0.0011	CcSEcCtD
Bosentan—Cough—Methotrexate—ankylosing spondylitis	0.000344	0.0011	CcSEcCtD
Bosentan—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000344	0.0011	CcSEcCtD
Bosentan—Dyspepsia—Prednisone—ankylosing spondylitis	0.000339	0.00108	CcSEcCtD
Bosentan—Arthralgia—Methotrexate—ankylosing spondylitis	0.000336	0.00107	CcSEcCtD
Bosentan—Chest pain—Methotrexate—ankylosing spondylitis	0.000336	0.00107	CcSEcCtD
Bosentan—Decreased appetite—Prednisone—ankylosing spondylitis	0.000335	0.00107	CcSEcCtD
Bosentan—Rash—Prednisolone—ankylosing spondylitis	0.000334	0.00107	CcSEcCtD
Bosentan—Dermatitis—Prednisolone—ankylosing spondylitis	0.000334	0.00107	CcSEcCtD
Bosentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000334	0.00107	CcSEcCtD
Bosentan—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000333	0.00106	CcSEcCtD
Bosentan—Fatigue—Prednisone—ankylosing spondylitis	0.000332	0.00106	CcSEcCtD
Bosentan—Headache—Prednisolone—ankylosing spondylitis	0.000332	0.00106	CcSEcCtD
Bosentan—Discomfort—Methotrexate—ankylosing spondylitis	0.000332	0.00106	CcSEcCtD
Bosentan—Constipation—Prednisone—ankylosing spondylitis	0.000329	0.00105	CcSEcCtD
Bosentan—Dizziness—Triamcinolone—ankylosing spondylitis	0.000322	0.00103	CcSEcCtD
Bosentan—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000322	0.00103	CcSEcCtD
Bosentan—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000322	0.00103	CcSEcCtD
Bosentan—Infection—Methotrexate—ankylosing spondylitis	0.00032	0.00102	CcSEcCtD
Bosentan—Asthenia—Betamethasone—ankylosing spondylitis	0.000317	0.00101	CcSEcCtD
Bosentan—Asthenia—Dexamethasone—ankylosing spondylitis	0.000317	0.00101	CcSEcCtD
Bosentan—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000316	0.00101	CcSEcCtD
Bosentan—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000315	0.00101	CcSEcCtD
Bosentan—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000315	0.00101	CcSEcCtD
Bosentan—Nausea—Prednisolone—ankylosing spondylitis	0.000315	0.00101	CcSEcCtD
Bosentan—Pruritus—Betamethasone—ankylosing spondylitis	0.000313	0.001	CcSEcCtD
Bosentan—Pruritus—Dexamethasone—ankylosing spondylitis	0.000313	0.001	CcSEcCtD
Bosentan—Skin disorder—Methotrexate—ankylosing spondylitis	0.000313	0.000999	CcSEcCtD
Bosentan—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000311	0.000994	CcSEcCtD
Bosentan—Vomiting—Triamcinolone—ankylosing spondylitis	0.00031	0.00099	CcSEcCtD
Bosentan—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000309	0.000988	CcSEcCtD
Bosentan—Rash—Triamcinolone—ankylosing spondylitis	0.000307	0.000982	CcSEcCtD
Bosentan—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000307	0.000981	CcSEcCtD
Bosentan—Anorexia—Methotrexate—ankylosing spondylitis	0.000307	0.00098	CcSEcCtD
Bosentan—Rash—Methylprednisolone—ankylosing spondylitis	0.000307	0.00098	CcSEcCtD
Bosentan—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000306	0.000979	CcSEcCtD
Bosentan—Urticaria—Prednisone—ankylosing spondylitis	0.000306	0.000978	CcSEcCtD
Bosentan—Headache—Triamcinolone—ankylosing spondylitis	0.000305	0.000976	CcSEcCtD
Bosentan—Headache—Methylprednisolone—ankylosing spondylitis	0.000305	0.000973	CcSEcCtD
Bosentan—Body temperature increased—Prednisone—ankylosing spondylitis	0.000305	0.000973	CcSEcCtD
Bosentan—Abdominal pain—Prednisone—ankylosing spondylitis	0.000305	0.000973	CcSEcCtD
Bosentan—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000303	0.000967	CcSEcCtD
Bosentan—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000303	0.000967	CcSEcCtD
Bosentan—Hypotension—Methotrexate—ankylosing spondylitis	0.000301	0.000961	CcSEcCtD
Bosentan—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000293	0.000937	CcSEcCtD
Bosentan—Dizziness—Dexamethasone—ankylosing spondylitis	0.000292	0.000934	CcSEcCtD
Bosentan—Dizziness—Betamethasone—ankylosing spondylitis	0.000292	0.000934	CcSEcCtD
Bosentan—Insomnia—Methotrexate—ankylosing spondylitis	0.000291	0.00093	CcSEcCtD
Bosentan—Nausea—Triamcinolone—ankylosing spondylitis	0.00029	0.000925	CcSEcCtD
Bosentan—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000289	0.000923	CcSEcCtD
Bosentan—Nausea—Methylprednisolone—ankylosing spondylitis	0.000289	0.000923	CcSEcCtD
Bosentan—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000287	0.000917	CcSEcCtD
Bosentan—Somnolence—Methotrexate—ankylosing spondylitis	0.000286	0.000914	CcSEcCtD
Bosentan—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000284	0.000907	CcSEcCtD
Bosentan—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000283	0.000905	CcSEcCtD
Bosentan—Vomiting—Betamethasone—ankylosing spondylitis	0.000281	0.000898	CcSEcCtD
Bosentan—Vomiting—Dexamethasone—ankylosing spondylitis	0.000281	0.000898	CcSEcCtD
Bosentan—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00028	0.000894	CcSEcCtD
Bosentan—Rash—Betamethasone—ankylosing spondylitis	0.000279	0.000891	CcSEcCtD
Bosentan—Rash—Dexamethasone—ankylosing spondylitis	0.000279	0.000891	CcSEcCtD
Bosentan—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000279	0.00089	CcSEcCtD
Bosentan—Dermatitis—Betamethasone—ankylosing spondylitis	0.000279	0.00089	CcSEcCtD
Bosentan—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000278	0.000888	CcSEcCtD
Bosentan—Fatigue—Methotrexate—ankylosing spondylitis	0.000278	0.000887	CcSEcCtD
Bosentan—Headache—Betamethasone—ankylosing spondylitis	0.000277	0.000885	CcSEcCtD
Bosentan—Headache—Dexamethasone—ankylosing spondylitis	0.000277	0.000885	CcSEcCtD
Bosentan—Asthenia—Prednisone—ankylosing spondylitis	0.000276	0.000883	CcSEcCtD
Bosentan—Pain—Methotrexate—ankylosing spondylitis	0.000275	0.000879	CcSEcCtD
Bosentan—Pruritus—Prednisone—ankylosing spondylitis	0.000273	0.000871	CcSEcCtD
Bosentan—Diarrhoea—Prednisone—ankylosing spondylitis	0.000264	0.000842	CcSEcCtD
Bosentan—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000263	0.000841	CcSEcCtD
Bosentan—Nausea—Betamethasone—ankylosing spondylitis	0.000263	0.000839	CcSEcCtD
Bosentan—Nausea—Dexamethasone—ankylosing spondylitis	0.000263	0.000839	CcSEcCtD
Bosentan—Urticaria—Methotrexate—ankylosing spondylitis	0.000256	0.000817	CcSEcCtD
Bosentan—Dizziness—Prednisone—ankylosing spondylitis	0.000255	0.000814	CcSEcCtD
Bosentan—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000254	0.000813	CcSEcCtD
Bosentan—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000254	0.000813	CcSEcCtD
Bosentan—Vomiting—Prednisone—ankylosing spondylitis	0.000245	0.000782	CcSEcCtD
Bosentan—Rash—Prednisone—ankylosing spondylitis	0.000243	0.000776	CcSEcCtD
Bosentan—Dermatitis—Prednisone—ankylosing spondylitis	0.000243	0.000775	CcSEcCtD
Bosentan—Headache—Prednisone—ankylosing spondylitis	0.000241	0.000771	CcSEcCtD
Bosentan—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000237	0.000758	CcSEcCtD
Bosentan—Asthenia—Methotrexate—ankylosing spondylitis	0.000231	0.000738	CcSEcCtD
Bosentan—Nausea—Prednisone—ankylosing spondylitis	0.000229	0.000731	CcSEcCtD
Bosentan—Pruritus—Methotrexate—ankylosing spondylitis	0.000228	0.000728	CcSEcCtD
Bosentan—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00022	0.000704	CcSEcCtD
Bosentan—Dizziness—Methotrexate—ankylosing spondylitis	0.000213	0.00068	CcSEcCtD
Bosentan—Vomiting—Methotrexate—ankylosing spondylitis	0.000205	0.000654	CcSEcCtD
Bosentan—Rash—Methotrexate—ankylosing spondylitis	0.000203	0.000648	CcSEcCtD
Bosentan—Dermatitis—Methotrexate—ankylosing spondylitis	0.000203	0.000648	CcSEcCtD
Bosentan—Headache—Methotrexate—ankylosing spondylitis	0.000202	0.000644	CcSEcCtD
Bosentan—Nausea—Methotrexate—ankylosing spondylitis	0.000191	0.000611	CcSEcCtD
